Wall Street Zen Upgrades Rapid Micro Biosystems (NASDAQ:RPID) to “Hold”

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Monday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $8.00.

Rapid Micro Biosystems Stock Up 8.3%

Shares of Rapid Micro Biosystems stock opened at $3.14 on Monday. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. Rapid Micro Biosystems has a 12-month low of $0.96 and a 12-month high of $4.50. The firm has a market capitalization of $139.16 million, a PE ratio of -3.11 and a beta of 1.36. The stock’s fifty day moving average is $3.53 and its 200-day moving average is $3.32.

Rapid Micro Biosystems (NASDAQ:RPID) last issued its quarterly earnings results on Friday, November 7th. The company reported ($0.26) EPS for the quarter, meeting the consensus estimate of ($0.26). Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. The business had revenue of $7.84 million during the quarter, compared to the consensus estimate of $7.60 million. Equities analysts anticipate that Rapid Micro Biosystems will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Rapid Micro Biosystems

A number of hedge funds and other institutional investors have recently bought and sold shares of RPID. Evernest Financial Advisors LLC grew its holdings in shares of Rapid Micro Biosystems by 355.1% during the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock worth $669,000 after purchasing an additional 156,234 shares during the last quarter. Vanguard Group Inc. lifted its position in Rapid Micro Biosystems by 6.7% during the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock worth $3,223,000 after buying an additional 60,655 shares in the last quarter. XTX Topco Ltd bought a new stake in Rapid Micro Biosystems during the 2nd quarter worth about $144,000. Dimensional Fund Advisors LP grew its holdings in Rapid Micro Biosystems by 37.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after acquiring an additional 15,255 shares during the last quarter. Finally, American Century Companies Inc. acquired a new stake in Rapid Micro Biosystems in the 1st quarter valued at about $31,000. 52.60% of the stock is owned by institutional investors and hedge funds.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.